William Sandborn, MD, chief of the Division of Gastroenterology and director of the Inflammatory Bowel Disease Center, is one of the world’s top experts in the management of ulcerative colitis and Crohns disease. His groundbreaking research has been instrumental to developing modern treatments for IBD.

A recent study published using a treatment known for psoriasis and arthritis as a new induction and maintenance therapy for ulcerative colitis has been published in the New England Journal of Medicine.